# Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma

> **NCT00434421** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 28 (actual)

## Conditions studied

- Allergy
- Asthma

## Interventions

- **DRUG:** Glycerinated German cockroach allergenic extract
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00434421
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434421, "Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma". Retrieved via MORVS 2026-11-15 from https://api.morvs.ai/clinical/NCT00434421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*